Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Diabetes Complications. 2019 Feb 6;33(5):356–362. doi: 10.1016/j.jdiacomp.2019.01.005

Table 2.

Multivariable adjusted means (95% confidence interval) for echocardiographic parameters according to fasting glucose trajectory group membership

Fasting Glucose (FG) trajectory group
Low-Stable Moderate-Stable Moderate-Increasing High-Stable High-Increasing
Left Ventricular Structure
Left ventricular mass index, g/m2.7
Year 25 31.8 (30.7, 32.9) 32.5 (32.0, 33.1) 33.3 (31.9, 34.7) 32.7 (32.0, 33.4) 32.8 (31.1, 34.6)
Year 30 36.8 (35.5, 38.0) 38.0 (37.3, 38.7) 39.5 (38.0, 40.9)* 38.8 (37.9, 39.7)* 38.2 (36.5, 39.9)
5-year change 4.8 (3.6, 6.0) 5.5 (4.9, 6.1) 6.4 (5.1, 7.6) 6.2 (5.5, 6.9) 5.5 (3.7, 7.2)
Relative Wall Thickness
Year 25 0.32 (0.31, 0.32) 0.31 (0.31, 0.32) 0.31 (0.30, 0.32) 0.31 (0.30, 0.32) 0.32 (0.30, 0.33)
Year 30 0.39 (0.38, 0.40) 0.39 (0.38, 0.40) 0.39 (0.38, 0.40) 0.39 (0.38, 0.40) 0.38 (0.36, 0.40)
5-year change 0.08 (0.06, 0.09) 0.08 (0.07, 0.08) 0.08 (0.07, 0.09) 0.08 (0.07, 0.08) 0.07 (0.05, 0.08)
Left Ventricular Function
Ejection fraction, %
Year 25 62.2 (61.2, 63.3) 61.9 (61.3, 62.4) 62.33 (61.0, 63.6) 61.7 (61.0, 62.5) 61.2 (59.8, 62.6)
Year 30 59.9 (59.1, 60.8) 60.1 (59.7, 60.6) 59.3 (58.3, 60.3) 59.9 (59.2, 60.6) 59.6 (58.5, 60.8)
5-year change −2.0 (−2.8, −1.2) −1.7 (−2.1, −1.3) −2.7 (−3.7, −1.7) −1.9 (−2.6, −1.3) −2.1 (−3.2, −1.0)
E/e’ ratio
Year 25 6.90 (6.60, 7.19) 6.98 (6.83, 7.13) 7.09 (6.69, 7.49) 7.07 (6.85, 7.30) 7.06 (6.63, 7.49)
Year 30 6.84 (6.57, 7.11) 7.08 (6.94, 7.23) 7.18 (6.79, 7.58) 7.17 (6.98, 7.37) 7.18 (6.71, 7.65)
5-year change −0.06 (−0.30, 0.18) 0.14 (0.01, 0.28) 0.19 (−0.11, 0.49) 0.19 (0.02, 0.36) 0.21 (−0.22, 0.63)
Lateral E’ velocity, cm/sec
Year 25 12.4 (11.9, 12.8) 12.0 (11.8, 12.2) 11.5 (11.1, 11.9)* 11.8 (11.5, 12.1) 11.8 (11.2, 12.3)
Year 30 12.0 (11.5, 12.4) 11.5 (11.3, 11.7) 11.1 (10.6, 11.6)* 11.4 (11.1, 11.7)* 11.4 (10.9, 12.0)
5-year change −0.2 (−0.6, 0.1) −0.5 (−0.7, −0.3) −0.7 (−1.0, −0.3) −0.5 (−0.7, −0.3) −0.5 (−0.9, 0.01)
Septal E’ velocity, cm/sec
Year 25 9.6 (9.2, 10.0) 9.4 (9.3, 9.6) 9.3 (9.0, 9.7) 9.4 (9.1, 9.6) 9.2 (8.8, 9.7)
Year 30 9.1 (8.7, 9.4) 9.0 (8.8, 9.2) 8.8 (8.4, 9.2) 9.1 (8.9, 9.3) 8.9 (8.5, 9.4)
5-year change −0.5 (−0.8, −0.2) −0.5 (−0.7, −0.4) −0.7 (−1.1, −0.3) −0.4 (−0.6, −0.2) −0.5 (−1.0, −0.1)
Mitral valve Peak A velocity, cm/sec
Year 25 61.2 (59.2, 63.1) 62.5 (61.5, 63.5) 63.0 (60.7, 65.3) 62.2 (60.7, 63.7) 61.9 (59.2, 64.6)
Year 30 65.1 (62.9, 67.4) 68.2 (67.1, 69.3)* 68.3 (66.1, 70.5) 68.7 (67.2, 70.2)* 68.2 (65.0, 71.4)
5-year change 3.7 (1.6, 5.7) 5.9 (5.0, 6.9) 5.7 (3.8, 7.6) 6.6 (5.4, 7.9)* 6.3 (3.7, 8.9)

Model adjustments included age, sex, race, field center, educational attainment, and cumulative measures for each of the following: number of years as a current smoker, milliliters of daily alcohol intake, body mass index, physical activity, systolic blood pressure, years of blood pressure-lowering medication use, heart rate, and baseline fasting glucose (and 5-year change models adjusted for year 25 echocardiographic measurement)

*

P<0.05 compared to Low-Stable fasting glucose trajectory group

P<0.05 compared to Low-Stable fasting glucose trajectory group after adjusted for the covariates in the model above and body mass index at time of echocardiography